4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-014400
Chief Commercial Officer gave up 16,450 shares (to pay taxes)
- Chief Commercial Officer acquired 39,996 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirby Daniel Gordon Chief Commercial Officer | 2026-02-10 | Option exercise | +39,996 | 69,996 | D: show line 1 in the form | ||
| Kirby Daniel Gordon Chief Commercial Officer | 2026-02-10 | Shares withheld for taxes | −16,450 | $2.60 | $42,770 | 53,546 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirby Daniel Gordon Chief Commercial Officer | 2026-02-10 | Option exercise · Restricted Stock Units | −39,996 | 80,004 | D: show line 3 in the form |
Loading xslF345X05/tm266006-1_4seq1.xml…